ALKBH7 and glioblastoma: The present study illustrated a new mechanism of glioblastoma resistance to TMZ, which based on GSCs‐exo educated TAAs delivering ALKBH7 to enhance APNG expression of GBM cells, which implied that targeting on ALKBH7/APNG regulation network may provide a new strategy of enhancing TMZ therapeutic effects against glioblastoma.